BioMarin Pharmaceutical announced new data from 13 studies showing that VOXZOGO (vosoritide) promotes growth in the foramen magnum and craniocervical junction in children with achondroplasia, including infants. This is significant as these skull regions are linked to serious complications in achondroplasia. The company also submitted a supplemental New Drug Application for VOXZOGO to treat hypochondroplasia, aiming for a 2027 launch if approved. Additional data on bone strength and next-gen treatments like BMN 333 were also presented, highlighting BioMarin's commitment to improving outcomes for children with skeletal dysplasias.
BioMarin's new data on achondroplasia and hypochondroplasia treatment provides important medical insights. For readers following the Health sector, here is Pluang's market snapshot as of Oct 09, 2026 18:51 WIB: out of 128 priced US Health-sector stocks, 71 rose and 49 fell. Notable movers include NUVB at USD 5.22 with a 1-day change of +5.45% and 0% sell / 100% buy order activity, BIO at USD 375.02 up +4.06% with a typical hold time of 58 days, and DFTX at USD 35.53 up +3.95% with 0% sell / 100% buy order activity.
At Malaysia's IGEM 2026, Sigenergy showcased its latest AI-driven energy technologies, including smart storage and inverter systems, highlighting its role in advancing sustainable energy. The company also signed MOUs with local partners Milieu and YT...
In 2026, Bitcoin has experienced 10 unusually large daily price moves of at least three standard deviations through October 9, surpassing the eight such moves recorded during the entire 2018 bear market. This is notable because overall annualized vol...
In 2026, Bitcoin's average annualized volatility has decreased to 40-47%, much lower than historical levels above 80%, suggesting calmer daily price movements. However, extreme price jumps—sudden large swings—have increased by 71% compared to 2018, i...
Hyperliquid will perform a network upgrade on October 10 at 4:15 a.m. ET, expected to last about 10 minutes. During this time, trading and on-chain activities may be temporarily interrupted. The maintenance is planned for early Saturday morning in th...
On October 9, Bitcoin spot ETFs attracted $21.13 million in net inflows, led by IBIT with $22.38 million, while Ether spot ETFs experienced $56.10 million in net outflows, marking nine straight sessions of decline. This divergence occurs amid ongoing...
